December 4, 2024 Health 0 Comments Does NICE consider real-world data (RWD) for HTA evaluations? – Healthcare Economist The answer is ‘yes’, but the question is in what manner? A paper by Che et al. (2024) examines the use of real-world data ... Read More
September 5, 2024 Health 0 Comments How should family spillover effects be measured in HTA? – Healthcare Economist A paper by Campbell et al. (2024) provides some guidance. The authors developed a series of recommendations based on ... Read More
July 2, 2024 Broader Value Elements 0 Comments HTA and cell and gene therapy – Healthcare Economist A paper by Drummond et al. (2023) examines how health technology assessment bodies deal with the challenge of value ... Read More